Eprocliv

Eprocliv combines Metformin Hydrochloride and Sitagliptin for oral use, supporting blood sugar management. This medication is commonly used in diabetes care to help regulate glucose levels.

Eprocliv is primarily used to manage type 2 diabetes. Metformin Hydrochloride helps reduce glucose production in the liver, while Sitagliptin works to increase insulin production. Together, they assist in maintaining stable blood sugar levels. This combination is often prescribed for individuals who require dual-action therapy to control their diabetes effectively.

Common effects of Eprocliv may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and tend to diminish as the body adjusts to the medication.

Eprocliv should be handled with care, especially for individuals with kidney or liver issues. It is important to follow the advice of a healthcare provider regarding its use. Regular monitoring of blood sugar levels is recommended while taking this medication.

Eprocliv may interact with certain medications, including those that affect kidney function or other diabetes treatments. Alcohol consumption should be limited, as it can enhance the risk of low blood sugar. Always consult a healthcare provider before combining Eprocliv with other medications.